GO:0046475 glycerophospholipid catabolic process: Breakdown Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0046475 describes the biochemical breakdown of glycerophospholipids, the major structural lipids of cell membranes.
• Phospholipase A2 enzymes are central catalysts of glycerophospholipid catabolism, releasing free fatty acids and lysophospholipids.
• Glycerophospholipid remodeling, including catabolic steps, is critical for orthoflavivirus infection and membrane homeostasis.
• Dysregulated glycerophospholipid catabolism contributes to metabolic diseases such as NAFLD and to cancer progression.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of catabolic enzyme function.
• Combining lipidomics with CRISPR screening provides a powerful approach to identify genes controlling glycerophospholipid breakdown [5,8].
Description
Glycerophospholipids are the most abundant lipids in biological membranes, and their controlled breakdown is essential for membrane remodeling, lipid signaling, and energy homeostasis. The Gene Ontology term GO:0046475, glycerophospholipid catabolic process, captures the chemical reactions and pathways that degrade these molecules into lysophospholipids, free fatty acids, glycerol, and other metabolites. This process is not merely a housekeeping function; it generates bioactive lipid mediators and regulates membrane composition in response to cellular stress and infection [2,7]. Researchers study glycerophospholipid catabolism to understand how cells maintain lipid homeostasis and how its dysregulation contributes to diseases ranging from metabolic dysfunction-associated steatotic liver disease to viral infection [2,5]. The availability of CRISPR-based tools now allows precise interrogation of the enzymes and regulatory factors that execute this catabolic process.
glycerophospholipid catabolic process At A Glance
| GO ID | GO:0046475 |
|---|---|
| GO term | glycerophospholipid catabolic process |
| Ontology | biological_process |
| Synonym | glycerophospholipid breakdown; glycerophospholipid catabolism; glycerophospholipid degradation; phosphoglyceride catabolic process; phosphoglyceride catabolism |
| Major function | Enzymatic breakdown of glycerophospholipids into lysophospholipids, free fatty acids, and other metabolites |
| Key enzymes | Phospholipase A2 family members, including PLA2G4D, and other lipases [7,8] |
| Cellular location | Membranes of the endoplasmic reticulum, Golgi, mitochondria, and other organelles [3,6] |
| Related process | Glycerophospholipid remodeling and lipid homeostasis [2,6] |
What Is GO:0046475?
GO:0046475, glycerophospholipid catabolic process, is defined as the chemical reactions and pathways resulting in the breakdown of glycerophospholipids, any derivative of glycerophosphate that contains at least one O-acyl, O-alkyl, or O-alkenyl group attached to the glycerol residue. In simpler terms, it is the set of enzymatic steps that dismantle membrane phospholipids into smaller products, including lysophospholipids, fatty acids, and water-soluble head groups.
Why Is glycerophospholipid catabolic process Important in Cell Biology?
Glycerophospholipid catabolism is fundamental to membrane plasticity, lipid signaling, and cellular adaptation to stress. It supplies precursors for eicosanoid and lysophospholipid signaling and is required for the membrane rearrangements that occur during viral infection and organelle biogenesis [2,6,7]. Because defects in this process are linked to metabolic liver disease and cancer, understanding its regulation offers therapeutic opportunities.
• Maintains membrane lipid composition and fluidity through controlled phospholipid turnover.
• Generates bioactive lipid mediators such as lysophospholipids and free fatty acids that participate in signaling.
• Supports orthoflavivirus replication by remodeling host membranes.
• Contributes to the pathogenesis of metabolic dysfunction-associated steatotic liver disease (NAFLD).
• Is implicated in cancer cell survival and proliferation through altered lipid metabolism.
• Provides targets for CRISPR-based functional genomics and drug discovery.
• Helps explain how cells degrade orphaned or damaged membrane proteins at the Golgi.
• Connects to bacterial lipid diversity and membrane homeostasis.
• Enables lipid nanoparticle-mediated delivery of CRISPR components to modulate lipid metabolism.
• Offers biomarkers for metabolic and infectious diseases.
What Happens During glycerophospholipid catabolic process?
Initiation by Phospholipases
In simple terms: Enzymes called phospholipases start the breakdown by cutting glycerophospholipids at specific positions.
The first step in glycerophospholipid catabolism is typically catalyzed by phospholipase A2 (PLA2) enzymes, which hydrolyze the sn-2 acyl bond to release a free fatty acid and a lysophospholipid. Different PLA2 isoforms, such as PLA2G4D, can also mediate transacylation reactions that remodel glycerophospholipids and acylglycerols. These initial cleavage events are critical for generating lipid second messengers and for membrane remodeling.
Lysophospholipid Processing
In simple terms: The lysophospholipids produced are further broken down or converted into other molecules.
Lysophospholipids generated by PLA2 activity can be further deacylated by lysophospholipases to produce glycerophosphate and free fatty acids, or they can be reacylated to restore membrane phospholipids. This balance between catabolism and remodeling is essential for maintaining membrane integrity and for responding to cellular stress.
Fatty Acid Release and Utilization
In simple terms: Free fatty acids released from glycerophospholipids can be used for energy or signaling.
The free fatty acids liberated during glycerophospholipid catabolism can enter beta-oxidation for ATP production or serve as precursors for eicosanoid synthesis. In metabolic tissues, this flux is tightly linked to energy status and can influence insulin sensitivity and inflammation.
Membrane Remodeling and Organelle Dynamics
In simple terms: Breakdown of glycerophospholipids helps reshape membranes during processes like vesicle trafficking and viral infection.
Glycerophospholipid catabolism contributes to the dynamic remodeling of organelle membranes, including the Golgi apparatus, where orphaned proteins are degraded by the Dsc ubiquitin ligase complex. Orthoflaviviruses exploit glycerophospholipid remodeling to build replication organelles, highlighting the importance of catabolic steps in infection.
Regulation by Metabolic Signals
In simple terms: The breakdown process is turned on or off by cellular signals that sense energy and stress.
Glycerophospholipid catabolism is regulated by metabolic cues, including succinylation-dependent resource allocation during antibiotic resistance. Lipid nanoparticle-mediated delivery of CRISPR-Cas9 against Rubicon modulates CD36 and glycerophospholipid metabolism, demonstrating that genetic perturbation can alter catabolic flux.
Key Genes Involved in GO:0046475 glycerophospholipid catabolic process
The following genes and proteins are experimentally implicated in glycerophospholipid catabolic process or its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PLA2G4D | Phospholipase A2 that mediates transacylation of glycerophospholipids and acylglycerols | Target for lipid remodeling studies |
| PLA2G4A | Cytosolic phospholipase A2 involved in arachidonic acid release | Inflammation and signaling research |
| PLA2G6 | Calcium-independent phospholipase A2 | Neurodegeneration models |
| PNPLA2 | Adipose triglyceride lipase with phospholipase activity | Lipid droplet metabolism |
| LPLAT | Lysophospholipid acyltransferase involved in remodeling | Membrane homeostasis |
| CD36 | Fatty acid translocase linked to glycerophospholipid metabolism | NAFLD and metabolic studies |
| Rubicon | Regulator of autophagy and lipid metabolism | NAFLD and CRISPR delivery |
| Dsc complex | Ubiquitin ligase complex degrading orphaned Golgi proteins | Golgi quality control |
| PLA2G15 | Lysosomal phospholipase A2 | Lysosomal lipid catabolism |
| ABHD12 | Lysophosphatidylserine lipase | Neuroinflammation |
| LYPLA1 | Lysophospholipase 1 | Lysophospholipid degradation |
| LYPLA2 | Lysophospholipase 2 | Lysophospholipid degradation |
| GDPD1 | Glycerophosphodiester phosphodiesterase | Bacterial lipid diversity |
| GDPD5 | Glycerophosphodiester phosphodiesterase | Membrane lipid turnover |
| PLA2G2A | Secretory phospholipase A2 | Host defense and inflammation |
| PLA2G5 | Secretory phospholipase A2 | Asthma and allergy models |
| PLA2G10 | Secretory phospholipase A2 | Antimicrobial activity |
How Is glycerophospholipid catabolic process Regulated?
Glycerophospholipid catabolic process is regulated at multiple levels, including transcriptional control of phospholipase genes, post-translational modifications such as succinylation, and feedback from lipid products. Metabolic signals, including nutrient availability and energy charge, modulate the activity of catabolic enzymes to match membrane remodeling demands [1,5]. In infection, viral factors can hijack this regulation to favor replication.
glycerophospholipid catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Rubicon | NAFLD | Liver-specific knockout mouse |
| CD36 | NAFLD and lipid uptake | Hepatocyte overexpression |
| PLA2G6 | Neurodegeneration | Knock-in mouse for point mutations |
| PLA2G4D | Lipid remodeling in skin | Keratinocyte knockout |
| Dsc complex | Golgi quality control | Knockout cell lines |
Metabolic Dysfunction-Associated Steatotic Liver Disease (NAFLD)
Glycerophospholipid catabolism is altered in NAFLD, where lipid nanoparticle-mediated CRISPR-Cas9 targeting of Rubicon ameliorates disease by modulating CD36 and glycerophospholipid metabolism. This suggests that catabolic enzymes are potential therapeutic targets.
Orthoflavivirus Infection
Glycerophospholipid remodeling, including catabolic steps, is critical for orthoflavivirus infection, as viruses require specific membrane lipid compositions for replication.
Cancer
Altered glycerophospholipid catabolism supports cancer cell proliferation by providing fatty acids for energy and membrane synthesis.
Neurodegeneration
Phospholipase A2 enzymes such as PLA2G6 are linked to neurodegeneration, and their catabolic products influence neuroinflammation.
From glycerophospholipid catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate glycerophospholipid catabolism? | CRISPR knockout cell line |
| Does a specific point mutation alter enzyme activity? | Point mutation knock-in |
| How does overexpression affect lipid flux? | Overexpression cell line |
| Where is the enzyme localized? | Tagged knock-in |
| Which genes control catabolism in a genome-wide screen? | CRISPR library screening |
| How does catabolism change in disease? | Patient-derived organoids |
How to Study the glycerophospholipid catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lipidomics | Glycerophospholipid and metabolite levels | Disease profiling |
| CRISPR screen | Gene essentiality for catabolism | Target discovery |
| Activity assay | Enzyme kinetics | Mechanistic studies |
| Imaging | Subcellular localization | Organelle dynamics |
| RNA-seq | Transcriptional changes | Pathway analysis |
| Proteomics | Protein abundance and modifications | Regulation studies |
| Metabolic flux analysis | Carbon flow through pathways | Metabolic engineering |
Lipidomics
Mass spectrometry-based lipidomics quantifies glycerophospholipid species and their catabolic products, revealing flux changes.
CRISPR Screening
Genome-wide CRISPR knockout screens identify genes required for glycerophospholipid catabolism under specific conditions.
Enzyme Activity Assays
In vitro assays using fluorescent or radiolabeled substrates measure phospholipase activity.
Imaging
Fluorescence microscopy with lipid probes visualizes membrane remodeling and enzyme localization.
How CRISPR Can Be Used to Study GO:0046475 glycerophospholipid catabolic process
Knockout
CRISPR knockout of phospholipase genes ablates catabolic activity, enabling loss-of-function studies in cell models.
Point Mutation
Point mutations can be introduced to mimic disease-associated variants or to dissect catalytic residues.
Knock-in
Knock-in of tagged enzymes allows tracking of localization and interactions.
Overexpression
Overexpression of catabolic enzymes increases flux and can model gain-of-function states.
How EDITGENE Supports glycerophospholipid catabolic process Research
Researchers studying glycerophospholipid catabolic process-related genes often need to determine whether a candidate gene is causally involved in lipid breakdown, membrane remodeling, or disease progression. EDITGENE provides tailored CRISPR services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for glycerophospholipid catabolic process research.
Frequently Asked Questions About glycerophospholipid catabolic process
What is glycerophospholipid catabolic process?
It is the set of biochemical reactions that break down glycerophospholipids into smaller products such as lysophospholipids and fatty acids.
What genes are involved in glycerophospholipid catabolic process?
Key genes include PLA2G4D, PLA2G4A, PLA2G6, PNPLA2, and others encoding phospholipases and lipases [7,8].
What is the GO ID for glycerophospholipid catabolic process?
The GO ID is GO:0046475.
Why is glycerophospholipid catabolism important?
It maintains membrane homeostasis, generates signaling lipids, and is implicated in diseases like NAFLD and viral infection [2,5].
Which enzymes catalyze glycerophospholipid breakdown?
Phospholipase A2 enzymes are primary catalysts, with additional roles for lysophospholipases and glycerophosphodiester phosphodiesterases.
How is glycerophospholipid catabolism regulated?
It is regulated by metabolic signals, post-translational modifications, and feedback from lipid products [1,5].
What diseases are linked to glycerophospholipid catabolic process?
NAFLD, orthoflavivirus infection, cancer, and neurodegeneration [2,5,7].
How can CRISPR be used to study glycerophospholipid catabolism?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of catabolic genes.
What methods measure glycerophospholipid catabolism?
Lipidomics, enzyme activity assays, imaging, and CRISPR screens are commonly used [5,7].
Where can I get CRISPR cell models for glycerophospholipid catabolic genes?
EDITGENE provides custom knockout, point mutation, knock-in, and overexpression services.
Conclusion
Glycerophospholipid catabolic process (GO:0046475) is a fundamental biological process that controls membrane lipid composition and generates bioactive mediators. Its dysregulation is linked to metabolic liver disease, viral infection, cancer, and neurodegeneration [2,5,7]. CRISPR-based models are essential for dissecting the causal roles of catabolic enzymes and for identifying new therapeutic targets. EDITGENE offers comprehensive services to accelerate this research.
References
- 1. Wu JH et al.. 2025. Metabolism-dependent succinylation governs resource allocation for antibiotic resistance.. Sci Adv 11(34):eadu2856 PMID: 40845110
- 2. Hehner J et al.. 2024. Glycerophospholipid remodeling is critical for orthoflavivirus infection.. Nat Commun 15(1):8683 PMID: 39375358
- 3. Weyer Y et al.. 2024. The Dsc ubiquitin ligase complex identifies transmembrane degrons to degrade orphaned proteins at the Golgi.. Nat Commun 15(1):9257 PMID: 39461958
- 4. López-Lara IM et al.. 2017. Bacterial lipid diversity.. Biochim Biophys Acta Mol Cell Biol Lipids 1862(11):1287-1299 PMID: 27760387
- 5. Bai Y et al.. 2024. Lipid Nanoparticle-Mediated Delivery of CRISPR-Cas9 Against Rubicon Ameliorates NAFLD by Modulating CD36 Along with Glycerophospholipid Metabolism.. Adv Sci (Weinh) 11(31):e2400493 PMID: 38894572
- 6. Chauhan N et al.. 2016. Lipid topogenesis--35years on.. Biochim Biophys Acta 1861(8 Pt B):757-766 PMID: 26946259
- 7. Murakami M et al.. 2020. Updating Phospholipase A(2) Biology.. Biomolecules 10(10) PMID: 33086624
- 8. Breithofer J et al.. 2024. Phospholipase A2 group IVD mediates the transacylation of glycerophospholipids and acylglycerols.. J Lipid Res 65(12):100685 PMID: 39490928
